Giridhara R. Jayandharan

Employment

• Indian Institute of Technology Kanpur Professor
  2019 - Present
• Indian Institute of Technology Kanpur Associate Professor
  2014 - 2019
• Christian Medical College & Hospital Associate Professor
  2013 - 2014
• Christian Medical College & Hospital Adjunct Scientist
  2010 - 2014
• Christian Medical College & Hospital Assistant Professor
  2008 - 2013

Education

• University of Florida Postdoctoral Fellow
  2007 - 2009
• Christian Medical College PhD
  2003 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Combination Gene Therapy with AAV-Based Vectors Ameliorates the Phenotype of Type 2 Diabetes in Diet-Induced Obese and db/db Mice
  Molecular Pharmaceutics 2026 DOI: 10.1021/acs.molpharmaceut.5c01896
  +Save
• AAV-mediated combination gene therapy of inducible Caspase 9 and miR-199a-5p is therapeutic in hepatocellular carcinoma
  Cancer Gene Therapy 2024 DOI: 10.1038/s41417-024-00844-x
  +Save
• Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma
  ACS Omega 2024 DOI: 10.1021/acsomega.4c03949
  +Save
• AAV mediated repression of Neat1 lncRNA combined with F8 gene augmentation mitigates pathological mediators of joint disease in haemophilia
  Journal of Cellular and Molecular Medicine 2024 DOI: 10.1111/jcmm.18460
  +Save
• Inducible caspase 9-mediated suicide gene therapy using AAV6 vectors in a murine model of breast cancer
  Molecular Therapy Methods & Clinical Development 2023 DOI: 10.1016/j.omtm.2023.101166
  +Save
• Potential role of long non‐coding RNA H19 and Neat1 in haemophilic arthropathy
  Journal of Cellular and Molecular Medicine 2023 DOI: 10.1111/jcmm.17770
  +Save
• Safety of Adeno-associated virus-based vector-mediated gene therapy—impact of vector dose
  Cancer Gene Therapy 2022 DOI: 10.1038/s41417-021-00413-6
  +Save
• Vector engineering, strategies and targets in cancer gene therapy
  Cancer Gene Therapy 2022 DOI: 10.1038/s41417-021-00331-7
  +Save
• Evaluation of the Anticancer Activity of pH-Sensitive Polyketal Nanoparticles for Acute Myeloid Leukemia
  Molecular Pharmaceutics 2021 DOI: 10.1021/acs.molpharmaceut.0c01243
  +Save
• Gene Therapy: Contest between Adeno-Associated Virus and Host Cells and the Impact of UFMylation
  Molecular Pharmaceutics 2020 DOI: 10.1021/acs.molpharmaceut.0c00512
  +Save